Pacific Biosciences Of California | PACB - Ordinary Share Capital


Pacific Biosciences Of California reported $301.96M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Agilent USD 282.22M 478K Mar/2026
Bruker USD 152.22M 282K Mar/2026
Danaher USD 707.7M 800K Mar/2026
General Electric Aerospace USD 1.04B 5.43M Mar/2026
Illumina USD 151.91M 893K Mar/2026
Myriad Genetics USD 93.5M 400K Dec/2025
Pacific Biosciences Of California USD 301.96M 103K Dec/2025
Quidel USD 67.9M 0 Dec/2025
Revvity USD 111.8M 1.57M Mar/2026
Roche Holding CHF 795.62M 699.54K Dec/2025
Standard Biotools USD 386.38M 2.77M Dec/2025
Thermo Fisher Scientific USD 371.62M 4.09M Mar/2026
Waters USD 98.17M 89K Mar/2026